Literature DB >> 21274866

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

James E Nelson1, Laura Wilson, Elizabeth M Brunt, Matthew M Yeh, David E Kleiner, Aynur Unalp-Arida, Kris V Kowdley.   

Abstract

UNLABELLED: Previous studies examining the relationship between hepatic iron deposition and histological severity in nonalcoholic fatty liver disease (NAFLD) have been inconclusive. The goal of this study was to examine the relationship between hepatic iron deposition and liver histology in 849 patients enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network. Hepatic iron staining was performed in a central laboratory, and the stains were scored for grade and cellular and parenchymal localization by a central pathology committee; the relationship between the grade and pattern of iron deposition and the clinical, laboratory, and histological variables was examined with univariate and multivariate analyses. Stainable hepatic iron was present in 293 of 849 patients (34.5%) in one of three histological patterns: a hepatocellular (HC) pattern [63/849 (7.4%)], a reticuloendothelial system (RES) cell pattern [91/849 (10.7%)], or a mixed RES/HC pattern [139/849 (16.4%)]. Patients with the RES iron-staining pattern were more likely to have advanced fibrosis compared to those with those with HC iron (P = 0.01). Patients with RES iron were also more likely to have advanced histological features such as fibrosis (P = 0.049), portal inflammation (P = 0.002), HC ballooning (P = 0.006), and definite nonalcoholic steatohepatitis (P = 0.007) compared to those with patients with HC or mixed iron patterns. The presence of RES iron (odds ratio = 1.60, 95% confidence interval = 1.10-2.33, P = 0.015) was independently associated with advanced hepatic fibrosis on multiple regression analysis after adjustments for age, gender, diabetes status, and body mass index.
CONCLUSION: The presence and pattern of hepatic iron deposition are associated with distinct histological features in patients with NAFLD and may have implications for pathophysiology and therapy.
Copyright © 2010 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21274866      PMCID: PMC3058264          DOI: 10.1002/hep.24038

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  50 in total

1.  Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance.

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

2.  Hepatic iron and nonalcoholic fatty liver disease.

Authors:  Z M Younossi; T Gramlich; B R Bacon; C A Matteoni; N Boparai; R O'Neill; A J McCullough
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

3.  Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

Authors:  Pauline Lee; Hongfan Peng; Terri Gelbart; Lei Wang; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 4.  Pathology of hepatic iron overload.

Authors:  Elizabeth M Brunt
Journal:  Semin Liver Dis       Date:  2005-11       Impact factor: 6.115

5.  Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.

Authors:  Paolo Sorrentino; Salvatore D'Angelo; Umberto Ferbo; Pietro Micheli; Alessandra Bracigliano; Raffaela Vecchione
Journal:  J Hepatol       Date:  2008-11-14       Impact factor: 25.083

Review 6.  Pathology of hepatic iron overload.

Authors:  Yves Deugnier; Bruno Turlin
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

7.  Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.

Authors:  Elmar Aigner; Igor Theurl; Milan Theurl; Dieter Lederer; Heike Haufe; Otto Dietze; Michael Strasser; Christian Datz; Guenter Weiss
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045

8.  Signaling role of intracellular iron in NF-kappaB activation.

Authors:  Shigang Xiong; Hongyun She; Heigo Takeuchi; Bora Han; John F Engelhardt; C H Barton; Ebrahim Zandi; Cecilia Giulivi; Hidekazu Tsukamoto
Journal:  J Biol Chem       Date:  2003-03-11       Impact factor: 5.157

Review 9.  Iron-dependent activation of NF-kappaB in Kupffer cells: a priming mechanism for alcoholic liver disease.

Authors:  Shigang Xiong; Hongyun She; Chin K Sung; Hidekazu Tsukamoto
Journal:  Alcohol       Date:  2003-06       Impact factor: 2.405

10.  Signaling role of iron in NF-kappa B activation in hepatic macrophages.

Authors:  Shigang Xiong; Hongyun She; Hidekazu Tsukamoto
Journal:  Comp Hepatol       Date:  2004-01-14
View more
  98 in total

1.  Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.

Authors:  Bryan D Maliken; William F Avrin; James E Nelson; Jody Mooney; Sankaran Kumar; Kris V Kowdley
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

2.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Kris V Kowdley; Patricia Belt; Laura A Wilson; Matthew M Yeh; Brent A Neuschwander-Tetri; Naga Chalasani; Arun J Sanyal; James E Nelson
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

Review 3.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

4.  Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.

Authors:  Ali Afsari; Edward Lee; Babak Shokrani; Tina Boortalary; Zaki A Sherif; Mehdi Nouraie; Adeyinka O Laiyemo; Kawtar Alkhalloufi; Hassan Brim; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2017-06-13       Impact factor: 3.199

Review 5.  Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?

Authors:  Bülent Baran; Filiz Akyüz
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 6.  Is That Possible to Stop or Cease the NASH to Turn into HCC?

Authors:  Ahmet Uygun
Journal:  J Gastrointest Cancer       Date:  2017-09

7.  Kupffer cell depletion protects against the steatosis, but not the liver damage, induced by marginal-copper, high-fructose diet in male rats.

Authors:  Ming Song; Dale A Schuschke; Zhanxiang Zhou; Wei Zhong; Jiayuan Zhang; Xiang Zhang; Yuhua Wang; Craig J McClain
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-26       Impact factor: 4.052

Review 8.  Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use.

Authors:  D Marti-Aguado; A Rodríguez-Ortega; A Alberich-Bayarri; L Marti-Bonmati
Journal:  Abdom Radiol (NY)       Date:  2020-08-28

Review 9.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

10.  Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Authors:  Bryan D Maliken; James E Nelson; Heather M Klintworth; Mary Beauchamp; Matthew M Yeh; Kris V Kowdley
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.